|Wang Yi Talks about the Five-point Consensus Reached at the First Meeting of the International Forum on COVID-19 Vaccine Cooperation|
On the evening of August 5, 2021, State Councilor and Foreign Minister Wang Yi hosted the First Meeting of the International Forum on COVID-19 Vaccine Cooperation and summarized the five-point consensus reached at the meeting.
First, all participants reaffirm the importance of the COVID-19 vaccine as a global public good. We call on all parties to continue their efforts to achieve the accessibility and affordability of vaccines in developing countries, and strengthen cooperation between governments, enterprises and international organizations to provide vaccines for developing countries, especially the least developed countries, as much as possible.
Second, all parties agree that the vaccine research, development and production should be carried out with the highest health standards in accordance with the requirements of the World Health Organization (WHO), so as to provide safe, effective, high-quality and affordable COVID-19 vaccines, and increase vaccine production capacity in developing countries through exports, donations, joint research, licensed production and technology transfer.
Third, all parties support an early decision by the World Trade Organization and other international institutions on the exemption of intellectual property rights for COVID-19 vaccines. We look forward to continued support from all countries in advancing the COVID-19 Vaccines Global Access, and call on multilateral financial institutions to provide inclusive financing support for the procurement and production of vaccines by developing countries.
Fourth, all parties look forward to further strengthening international cooperation on vaccines and promoting the equitable and reasonable distribution of vaccines among countries around the world. We oppose vaccine nationalism, call for the lifting of export restrictions on vaccines and raw materials, and support domestic companies in international cooperation on vaccine research, development and production.
Fifth, all parties reaffirm the importance of the WHO Emergency Use Listing Procedure, and call on all governments to adopt scientific and non-discriminatory principles when studying entry control measures, respect the relevant WHO certification system, and strengthen communication and coordination of vaccine regulatory policies.